Literature DB >> 21862993

Diabetes: bardoxolone improves kidney function in type 2 diabetes.

Merlin C Thomas, Mark E Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21862993     DOI： 10.1038/nrneph.2011.114

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

1.  Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.

Authors:  Allan J Collins; Bertram Kasiske; Charles Herzog; Blanche Chavers; Robert Foley; David Gilbertson; Richard Grimm; Jiannong Liu; Thomas Louis; Willard Manning; Arthur Matas; Marshall McBean; Anne Murray; Wendy St Peter; Jay Xue; Qiao Fan; Haifeng Guo; Shuling Li; Suying Li; Tricia Roberts; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Roger Johnson; Daniel Sheets; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Pamela Frederick; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

2.  Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo.

Authors:  Hong Wang; Jeffrey L Garvin; Martin A D'Ambrosio; John R Falck; Pablo Leung; Ruisheng Liu; YiLin Ren; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

3.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

4.  Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.

Authors:  Zoltan Ungvari; Lora Bailey-Downs; Tripti Gautam; Rosario Jimenez; Gyorgy Losonczy; Cuihua Zhang; Praveen Ballabh; Fabio A Recchia; Donald C Wilkerson; William E Sonntag; Kevin Pearson; Rafael de Cabo; Anna Csiszar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-07       Impact factor: 4.733

5.  Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD.

Authors:  Pablo E Pergola; Melissa Krauth; J Warren Huff; Deborah A Ferguson; Stacey Ruiz; Colin J Meyer; David G Warnock
Journal:  Am J Nephrol       Date:  2011-04-21       Impact factor: 3.754

6.  Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.

Authors:  Keigyou Yoh; Aki Hirayama; Kazusa Ishizaki; Akiko Yamada; Masayoshi Takeuchi; Sho-ichi Yamagishi; Naoki Morito; Takako Nakano; Masami Ojima; Homare Shimohata; Ken Itoh; Satoru Takahashi; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2008-11       Impact factor: 1.891

7.  The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.

Authors:  Tao Jiang; Zheping Huang; Yifeng Lin; Zhigang Zhang; Deyu Fang; Donna D Zhang
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

8.  Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease.

Authors:  Mingzhan Xue; Qingwen Qian; Antonysunil Adaikalakoteswari; Naila Rabbani; Roya Babaei-Jadidi; Paul J Thornalley
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461
  8 in total
  6 in total

1.  Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation.

Authors:  Pengfei Liu; Wang Tian; Shasha Tao; Joseph Tillotson; E M Kithsiri Wijeratne; A A Leslie Gunatilaka; Donna D Zhang; Eli Chapman
Journal:  Cell Chem Biol       Date:  2019-08-08       Impact factor: 8.116

Review 2.  Diabetic nephropathy: diagnosis and treatment.

Authors:  Daniel Fineberg; Karin A M Jandeleit-Dahm; Mark E Cooper
Journal:  Nat Rev Endocrinol       Date:  2013-10-08       Impact factor: 43.330

3.  A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.

Authors:  Jun Wei; Hongyan Zhu; Kazuhiro Komura; Gabriel Lord; Michal Tomcik; Wenxia Wang; Sruthi Doniparthi; Zenshiro Tamaki; Monique Hinchcliff; Joerg H W Distler; John Varga
Journal:  Ann Rheum Dis       Date:  2013-03-20       Impact factor: 19.103

4.  Nrf2 activators as attractive therapeutics for diabetic nephropathy.

Authors:  Judy B de Haan
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461

Review 5.  Mechanisms of tissue injury in lupus nephritis.

Authors:  Tamara K Nowling; Gary S Gilkeson
Journal:  Arthritis Res Ther       Date:  2011-12-21       Impact factor: 5.156

6.  Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.

Authors:  Emma Börgeson; Catherine Godson
Journal:  Front Immunol       Date:  2012-10-18       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.